OZ HASIS: Open Payments
NPI 1245851930 · CEDARHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 43 payments from 10 companies in 2025. Trend: 2023 $58 · 2024 $149 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $278 |
| Teva Pharmaceuticals USA, Inc. | 10 | $171 |
| Otsuka America Pharmaceutical, Inc. | 3 | $152 |
| Alkermes, Inc. | 3 | $73 |
| Lundbeck LLC | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| ABBVIE INC. | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Corium, LLC | 2 | $18 |
Products named: COBENFY, ABILIFY MAINTENA, UZEDY, ARISTADA, Auvelity, FANAPT, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
